Giovanni Fabbrini Selected Research

Giovanni Fabbrini Research Topics

Disease

39	Parkinson Disease (Parkinson's Disease) 03/2022 - 10/2002
9	Dyskinesias (Dyskinesia) 01/2022 - 10/2002
8	Tremor (Tremors) 01/2022 - 10/2010
6	Movement Disorders (Movement Disorder) 01/2022 - 02/2009
5	Torticollis (Wryneck) 01/2022 - 03/2011
5	Dystonia (Limb Dystonia) 01/2019 - 07/2007
3	Hypokinesia (Bradykinesia) 01/2022 - 10/2016
3	Sleep Wake Disorders 12/2021 - 07/2014
3	Pain (Aches) 12/2021 - 04/2003
2	Dyspepsia (Indigestion) 01/2022 - 11/2020
2	Task-Specific Focal Dystonia 01/2020 - 02/2013
2	Blepharospasm 01/2020 - 03/2015
2	Disease Progression 01/2019 - 05/2012
1	Multiple Sclerosis 01/2022
1	COVID-19 11/2020
1	Gout 01/2020
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 10/2019
1	Psychotic Disorders (Schizoaffective Disorder) 10/2019
1	Spasm (Spasms) 05/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Essential Tremor (Essential Tremors) 11/2018
1	Fatigue 07/2014
1	Dementia (Dementias) 07/2014
1	Major Depressive Disorder (Major Depressive Disorders) 11/2012
1	Hypercholesterolemia 11/2012
1	Cognitive Dysfunction 06/2012
1	Overactive Urinary Bladder (Overactive Bladder) 09/2011
1	Urinary Incontinence 09/2011
1	Parkinsonian Disorders (Parkinsonism) 02/2011
1	Restless Legs Syndrome (Restless Legs) 10/2010
1	Parkinson Disease 11 11/2009
1	Epilepsy (Aura) 12/2007
1	Mood Disorders (Mood Disorder) 01/2005

Drug/Important Bio-Agent (IBA)

19	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 10/2002
6	Pharmaceutical PreparationsIBA 01/2019 - 04/2003
5	Botulinum Toxins (Botulinum Toxin)IBA 12/2021 - 03/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Carbidopa (Lodosyn)FDA LinkGeneric 06/2021 - 11/2016
3	Type A Botulinum Toxins (Botox)FDA Link 01/2020 - 03/2011
3	Dopamine Agonists (Dopamine Agonist)IBA 10/2019 - 01/2005
3	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 09/2010
2	Coffee FDA Link 01/2022 - 11/2020
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 04/2015
2	Caffeine (No Doz)FDA LinkGeneric 10/2021 - 01/2020
2	Biological ProductsIBA 01/2020 - 01/2016
2	FHDIBA 01/2020 - 02/2013
2	alpha-SynucleinIBA 01/2019 - 01/2016
2	Pramipexole (Mirapex)FDA LinkGeneric 10/2010 - 10/2002
1	ametantrone (HAQ)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	incobotulinumtoxinA FDA Link 12/2021
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 12/2020
1	OilsIBA 11/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	TeaIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 10/2019
1	Clozapine (Clozaril)FDA LinkGeneric 10/2019
1	pimavanserinIBA 10/2019
1	Serotonin (5 Hydroxytryptamine)IBA 10/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 07/2019
1	Propranolol (Inderal)FDA LinkGeneric 11/2018
1	propylene diquat (PDQ(+))IBA 07/2014
1	Apomorphine FDA Link 07/2014
1	Glucose (Dextrose)FDA LinkGeneric 11/2012
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2012
1	BilirubinIBA 11/2012
1	A-factor (Streptomyces)IBA 09/2012
1	Monoamine Oxidase (MAO)IBA 05/2012
1	Neuroprotective AgentsIBA 05/2012
1	Selegiline (E250)FDA LinkGeneric 05/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2011
1	Proteins (Proteins, Gene)FDA Link 11/2009
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2007
1	Adrenergic Agents (Adrenergic Drugs)IBA 07/2007
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2007
1	CannabinoidsIBA 07/2007
1	Opioid Analgesics (Opioids)IBA 07/2007
1	Amantadine (Aman)FDA LinkGeneric 07/2007
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2007
1	Leucine (L-Leucine)FDA Link 03/2006
1	Phosphotransferases (Kinase)IBA 03/2006
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2005
1	Pain-FreeIBA 04/2003
1	TabletsIBA 04/2003

Therapy/Procedure

17	Therapeutics 03/2022 - 07/2007
5	Activities of Daily Living (ADL) 03/2022 - 07/2010
3	Transcranial Magnetic Stimulation 01/2022 - 07/2007
3	Deep Brain Stimulation 01/2019 - 09/2010
2	General Anesthesia 01/2022 - 11/2020
2	Electrocoagulation (Electrocautery) 01/2022 - 01/2022
1	Personal Protective Equipment 11/2020
1	Occupational Therapy (Therapy, Occupational) 11/2020
1	Transcranial Direct Current Stimulation 10/2020
1	Cognitive Training 05/2019
1	Subcutaneous Infusions 07/2014
1	Contraindications 07/2014
1	Self Medication 01/2005